Croient Pharma Private Limited - Due diligence report

A 360° intelligence report on Croient Pharma Private Limited: trust score, financial health, credit view, compliance, directors, growth and …

2012-02-14 Thane, Maharashtra Active Unlisted Active Compliant
Share
Connect MCP
CP Croient Pharma Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Croient Pharma Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
85/100
Trust Score
Low Risk

Croient Pharma Private Limited is assessed as Low Risk with a Trust Score of 85/100. Croient Pharma Private Limited is an active private limited indian non-government company incorporated in 2012, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 10 Oct 2026 from the latest processed filings. Croient Pharma Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
85/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
74/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 60/100 Moderate
  • Open charges exceed net worth - secured lenders rank ahead.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 3 open (13.05 cr) · 2 satisfied (3.10 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others4 48.0 cr
Axis Bank Limited1 48.0 cr
Compliance Score: 74/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • Litigation present in 2 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
SHRIKANT HAMBIRRAO RANE 01234567 Director 01/04/2018 6 yrs Approved
PAWANKUMAR BABASAHEB ANKALKOPE 01234567 Director 01/04/2018 6 yrs Approved
DINESH BALKRISHNA SAWANT 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2024 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
3 allotment(s) · 3 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 95 · Distress 80
Growth signals & trust indicators
Revenue acceleration: +38% over 4 year(s).
Latest year revenue grew 1.42.
Profit expanded 2.1x year-on-year.
Asset base grew 24% - capacity expansion.
Operating for 14+ years.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 0.86 in a year.
3 open charge(s) registered - assets are encumbered.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence79/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment72/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 3 open charge(s) of 13.05 cr already registered.
  • Compliance record supports lending.
Investor view91/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
04 Jul 2023
Charge created
Axis Bank Limited - 6.25 cr
12 Jun 2023
Charge created
Others - 80.00 Lakh
31 Mar 2022
Share transfer (FY 2022)
2002.00000000 shares to Shrikant Hambirrai Rane
Share transfer (FY 2022)
2002.00000000 shares to Dinesh Balkrishna Sawant
10 Mar 2021
Director ceased
DIPANKAR GHOSH
09 Sep 2019
Charge satisfied
Others
30 Jul 2019
Charge created
Others - 6.00 cr
06 Sep 2018
Charge created
Others - 2.50 cr
31 Aug 2018
Charge satisfied
Others
21 Jul 2018
Securities allotted
250000 Equity Shares - 25.00 Lakh raised
12 Jun 2018
Securities allotted
4000 Equity Shares - 40,000.00 raised
07 May 2018
Securities allotted
90000 Equity Shares - 9.00 Lakh raised
31 Mar 2018
Share transfer (FY 2018)
4.00000000 shares to DIPANKAR DESHBANDHU GHOSH
10

Key Observations

Auto-generated from the data above
Revenue grew 61% over the last 4 financial year(s).
Net profit margin moved from 38% to 1.42.
Debt-to-equity stands at 2.1x - leverage worth monitoring.
Net worth is positive.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 3 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Gbj Infratech Private Limited U45202MH2011PTC219680 Thane, Maharashtra
THREE LEAF CONSULTING LLP AAD-2052 Thane, Maharashtra
Warhi Saai-T Infrastructure Private Limited U43299MH2023PTC398655 Thane, Maharashtra
Cactus It Services Private Limited U62099MH2024PTC436398 Thane, Maharashtra
Mumbai Natural Dairy Foods & Beverages Private Limited U15122MH2011PTC218229 Thane, Maharashtra
Kumars Telempathy Services Private Limited U74999MH2021PTC366961 Thane, Maharashtra
Sunimple International Consultancy Private Limited U70200MH2024PTC426353 Thane, Maharashtra
Securus Advisory Services (Opc) Private Limited U69100MH2024OPC429663 Thane, Maharashtra
Geet Developers Private Limited U70102MH2008PTC180701 Thane, Maharashtra
Octantis Services Private Limited U72900MH2017FTC292532 Thane, Maharashtra
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Croient Pharma Private Limited before audits and certifications: compliance score 74/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Croient Pharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Croient Pharma Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 85/100, distress signals and MSME payment-delay disclosures - know whether Croient Pharma Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Croient Pharma Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Croient Pharma Private Limited an active company?

Croient Pharma Private Limited has MCA status “Active” with a compliance score of 74/100 (Moderate).

Is Croient Pharma Private Limited financially healthy?

Croient Pharma Private Limited has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.

Should I do business with Croient Pharma Private Limited?

Its overall Trust Score is 85/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Croient Pharma Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Croient Pharma Private Limited have loans or charges against its assets?

3 open charge(s) are registered against its assets, and 2 earlier charge(s) stand satisfied.

Is Croient Pharma Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 74/100 (Moderate).

Is it risky to lend to Croient Pharma Private Limited?

Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.